S&P Equity Research analyst, H. Saftlas, is positive on Big Pharma stocks with expanding Oncology franchises.

Saftlas says, "We ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE